ConductScience.org, home

Paper41004586

Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.

Xu J and 16 others. Sci Adv, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV. Papers, record 41004586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004586

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.
PubMed
Journal
Sci Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-08-27
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Respiratory Syncytial Virus, HumanMajor topic
Genetic VectorsMajor topic
COVID-19 VaccinesMajor topic
Respiratory Syncytial Virus InfectionsMajor topic
Respiratory Syncytial Virus VaccinesMajor topic
Animals
Humans
Administration, Intranasal
Spike Glycoprotein, Coronavirus
Vaccines, Attenuated
Cricetinae
Antibodies, Viral
Vero Cells

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI112524NIAID NIH HHSUnited StatesP01AI112524PubMedNIH RePORTER
P01 AI175399NIAID NIH HHSUnited StatesP01AI175399PubMedNIH RePORTER
R01 AI185617NIAID NIH HHSUnited StatesR01AI185617PubMedNIH RePORTER
R21 AI180667NIAID NIH HHSUnited StatesR21AI180667PubMedNIH RePORTER
R01 AI093848NIAID NIH HHSUnited StatesR01AI093848PubMedNIH RePORTER
T32 AI165391NIAID NIH HHSUnited StatesT32AI165391PubMedNIH RePORTER
U19AI42733NIAID NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120844609Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity.mBio2010https://conductscience.org/library/papers/20844609PubMed
236722972SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.J Virol2023https://conductscience.org/library/papers/36722972PubMed
334103499A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.Nat Commun2021https://conductscience.org/library/papers/34103499PubMed
437883560Billions boost next-generation weapons against SARS-CoV-2.Science2023https://conductscience.org/library/papers/37883560PubMed
535239997A simple reverse genetics method to generate recombinant coronaviruses.EMBO Rep2022https://conductscience.org/library/papers/35239997PubMed
66281467Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides.J Virol1982https://conductscience.org/library/papers/6281467PubMed
732999025
Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
J Virol2020https://conductscience.org/library/papers/32999025PubMed
832978313Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.mBio2020https://conductscience.org/library/papers/32978313PubMed
933907312The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.Nat Microbiol2021https://conductscience.org/library/papers/33907312PubMed
1032979938Evasion of Type I Interferon by SARS-CoV-2.Cell Rep2020https://conductscience.org/library/papers/32979938PubMed
1135980204Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus.Microbiol Spectr2022https://conductscience.org/library/papers/35980204PubMed
1239302652FDA Approves Updated COVID-19 Vaccines.JAMA2024https://conductscience.org/library/papers/39302652PubMed
1333688034A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33688034PubMed
1440489985Virological characteristics of the SARS-CoV-2 NB.1.8.1 variant.Lancet Infect Dis2025https://conductscience.org/library/papers/40489985PubMed
1533514944Engineering SARS-CoV-2 using a reverse genetic system.Nat Protoc2021https://conductscience.org/library/papers/33514944PubMed
1627352927"Self-cleaving" 2A peptide from porcine teschovirus-1 mediates cleavage of dual fluorescent proteins in transgenic Eimeria tenella.Vet Res2016https://conductscience.org/library/papers/27352927PubMed
1737988285Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform.Elife2023https://conductscience.org/library/papers/37988285PubMed
1836302057Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.Science2022https://conductscience.org/library/papers/36302057PubMed
1911991994Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.J Virol2002https://conductscience.org/library/papers/11991994PubMed
2010805807Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10805807PubMed

See all 67 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42894965Transcription Regulatory Sequences in Coronaviruses: Mechanistic Foundations for Antivirals and Vaccines.J Microbiol Biotechnol2026https://conductscience.org/library/papers/42894965PubMed
42859170An efficient and versatile reverse genetics system for bovine coronavirus facilitates antiviral evaluation.Vet Res2026https://conductscience.org/library/papers/42859170PubMed
42781491Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.iScience2026https://conductscience.org/library/papers/42781491PubMed
42193385Mucosal Vaccine Development: From Adjuvant Design to Next-Generation Delivery Strategies.Biomedicines2026https://conductscience.org/library/papers/42193385PubMed
42112831A rapid yeast-based reverse genetics system reveals SARS-CoV-2 Omicron BA.2.86 variant spreads faster than Omicron JN.1 variant in primary human nasal and bronchial epithelial airway cultures.mBio2026https://conductscience.org/library/papers/42112831PubMed
42037408A novel replication-deficient feline herpesvirus type 1 vector-based vaccine provides strong immune protection in cats.J Virol2026https://conductscience.org/library/papers/42037408PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41004586

GET https://conductscience.org/api/papers/v1/41004586/references?page=2